How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

A Diabetes Drug Shows an Early Signal Against Chemotherapy Resistance in Pancreatic Cancer

calendar_today November 3, 2026 person NewTqnia domain newtqnia

In a 22-patient phase 2 trial, adding sitagliptin to gemcitabine and nab-paclitaxel produced a 36.4% response rate. Laboratory results suggest a possible resistance mechanism, but the uncontrolled single-center study cannot establish a survival benefit.

open_in_new Read original post